The Board of Directors of K-One Technology Berhad announced that the K-One Group’s wholly owned subsidiary, K-One MediTech Sdn. Bhd. (fka K-One Resources Sdn. Bhd.) has on 4 June 2021 received approval from the Medical Device Authority ("MDA") under the Ministry of Health, Malaysia for the sale of Low Dead Volume disposable syringes with needle in Malaysia. The LDV syringes with needle are suitable for COVID-19 vaccinations to reduce vaccine wastage and applicable to vaccinations in general. The K-One Group will sell the LDV syringes with needle as an authorised representative of Anhui Kangda Medical Products Co. Ltd. based in China with the LDV syringes with needle approved under K-One MediTech Sdn. Bhd. by MDA. The MDA has approved twelve LDV syringes with needle in total, consisting of 1ml and 3 ml LDV syringes respectively with each having six different combinations of needle gauges (ranging from 23G to 25G) and lengths (ranging from 19 mm to 38 mm) to suit various market requirements. The approval of the LDV syringes with needle is timely as the Malaysian government is stepping up the rollout of the COVID-19 vaccinations in the coming months in the fight against rising infections by pushing for herd immunity through vaccinations. The demand for LDV syringes with needle is expected to increase in tandem with the accelerated rollout of COVID-19 vaccinations in the months ahead. In this regard, the K-One Group is prepared to cater to the surge in requirements of LDV syringes with needle.